The risk too many people are taking with Ozempic and other GLP-1s.

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.

Every week, millions of Americans fill prescriptions for GLP-1 receptor agonists, drugs like Ozempic and…

Continue Reading


News Source: slate.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *